Regeneron Drug Approved to Help Prevent Severe COVID in Vulnerable After Exposure

WEDNESDAY, Aug. 4, 2021 -- A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration. The first dose of Regeneron ' s...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news